Prediction Markets in Clinical Trials and Drug Approval

This Viewpoint discusses the emergence of prediction markets for clinical trials and drug approvals, identifies the risks of these markets, and proposes oversight methods to develop potential benefits.

Authors

Genevieve P. Kanter (ORCID: https://orcid.org/0000-0002-3044-7829)

Institutions

University of Southern California (US)

Publication Details

Journal: JAMA Health Forum
Published: 2026-09-25
DOI: https://doi.org/10.1001/jamahealthforum.2026.2953
Primary Topic: Statistical Methods in Clinical Trials
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

article

Prediction Markets in Clinical Trials and Drug Approval

Genevieve P. Kanter

Sep 25, 2026

JAMA Health Forum

Statistical Methods in Clinical Trials

article

Prediction Markets in Clinical Trials and Drug Approval

Genevieve P. Kanter

September 25, 2026article en

Abstract

JAMA Health ForumVol. 7(9)

University of Southern California (US)

Openalex Percentile: Top 8%

Statistical Methods in Clinical Trials

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prediction Markets in Clinical Trials and Drug Approval — Genevieve P. Kanter · JAMA Health Forum (2026) | TGRS Research Map | TGRS